← Back to All Filings

Teradyne Director Marilyn Matz Files Form 144 to Sell 400 Shares

Low SignificanceOctober 21, 2026 at 5:37:30 PM UTC

TERADYNE, INC

$TER144CIK: 0000097210

Subscribe to track TER

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Proposed sale of 400 shares of Teradyne, Inc. ($TER) common stock valued at ~$140,000 by Director Marilyn Matz under a Rule 10b5-1 plan adopted on 02/13/2026.

Comprehensive Analysis

Insider Filing Analysis: Form 144

Company: Teradyne, Inc. (NASDAQ: TER)
Insider: Marilyn Matz (Director)
Filing Date: October 21, 2026

Transaction Summary

  • Security: Common Stock
  • Shares Proposed for Sale: 400 shares
  • Estimated Aggregate Market Value: $140,000.00 (~$350.00 per share)
  • Approximate Sale Date: October 21, 2026
  • Broker: Fidelity Brokerage Services LLC

Origin and History

  • Acquisition History: Acquired on May 9, 2024, via restricted stock vesting as equity compensation from the issuer.
  • Pre-Arranged Plan: Executed pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2026.
  • Recent Prior Activity (Past 3 Months):
    • August 17, 2026: 1,200 shares ($510,000.00)
    • September 15, 2026: 800 shares ($270,264.00)
    • September 17, 2026: 400 shares ($140,444.00)
    • October 15, 2026: 800 shares ($273,024.00)

Market & Trading Impact

  • Trading Significance: Low. The proposed transaction of 400 shares represents a negligible fraction of Teradyne's 156,340,750 outstanding shares. Furthermore, the sale is being conducted under a pre-established Rule 10b5-1 plan, indicating regular scheduled liquidity rather than a discretionary market-timing decision.
Topics:#Teradyne#TER#Form144#InsiderTrading#StockMarket

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.